4
Changes in Ownership
ANAPTYSBIO, INC Filed Acc 0001415889-24-023549
CHIEF FINANCIAL OFFICER sold 12,220 shares at an average $39.91 ($487,725)
- CHIEF FINANCIAL OFFICER acquired 16,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
MULROY DENNIS · CHIEF FINANCIAL OFFICER
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-09-14 | Exercise or conversion : show line 1 in the form 10b5-1 | +6,000 | 6,964 | D | ||
| 2024-09-16 | Sale : show line 2 in the form 10b5-1 | −2,220 | $38.93 | $86,425 | 4,744 | D |
| 2024-09-16 | Exercise or conversion : show line 3 in the form 10b5-1 | +10,000 | $20.16 | $201,600 | 14,744 | D |
| 2024-09-16 | Sale : show line 4 in the form 10b5-1 | −10,000 | $40.13 | $401,300 | 4,744 | D |
| Open-market sales · 12,220 sh · avg $39.91 · $487,725 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-09-14 | Exercise or conversion : show line 5 in the form 10b5-1 Restricted Stock Unit | −6,000 | 0 | D |
| 2024-09-16 | Exercise or conversion : show line 6 in the form 10b5-1 Employee Stock Option (right to buy) | −10,000 | 80,600 | D |
Loading xslF345X05/form4-09172024_100933.xml…